Your browser doesn't support javascript.
loading
Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial.
Ludvigsson, Johnny; Sumnik, Zdenek; Pelikanova, Terezie; Nattero Chavez, Lia; Lundberg, Elena; Rica, Itxaso; Martínez-Brocca, Maria A; Ruiz de Adana, Marisol; Wahlberg, Jeanette; Katsarou, Anastasia; Hanas, Ragnar; Hernandez, Cristina; Clemente León, Maria; Gómez-Gila, Ana; Lind, Marcus; Lozano, Marta Ferrer; Sas, Theo; Samuelsson, Ulf; Pruhova, Stepanka; Dietrich, Fabricia; Puente Marin, Sara; Nordlund, Anders; Hannelius, Ulf; Casas, Rosaura.
Afiliação
  • Ludvigsson J; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences and Crown Princess Victoria Children's Hospital, Linköping University, Linköping, Sweden johnny.ludvigsson@liu.se.
  • Sumnik Z; Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Pelikanova T; Diabetes Centre of the Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
  • Nattero Chavez L; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Lundberg E; Institution of Clinical Science, Department of Pediatrics, Umeå University, Norrland University Hospital, Umeå, Sweden.
  • Rica I; Department of Pediatric Endocrinology, Cruces University Hospital, CIBERDEM, Bilbao, Spain.
  • Martínez-Brocca MA; Department of Endocrinology, Virgen Macarena Hospital, Sevilla, Spain.
  • Ruiz de Adana M; Department of Adult Endocrinology and Diabetology, General University Hospital, Instituto de Biomedicina de Málaga, CIBERDEM, Malaga, Spain.
  • Wahlberg J; Departments of Endocrinology Region Östergötland and Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Katsarou A; Department of Endocrinology, Skåne University Hospital, Malmö, Sweden.
  • Hanas R; Department of Pediatrics, NU Hospital Group, Uddevalla, Sweden.
  • Hernandez C; Department of Endocrinology and Nutrition, Vall d'Hebron Hospital, CIBERDEM, Barcelona, Spain.
  • Clemente León M; Department of Endocrinology and Nutrition, Vall d'Hebron Hospital, CIBERDEM, Barcelona, Spain.
  • Gómez-Gila A; Pediatric Endocrinology Service, Virgen del Rocío University Hospital, Sevilla, Spain.
  • Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Lozano MF; Department of Medicine, Department of Medicine, Uddevalla, Sweden.
  • Sas T; Department of Pediatric Endocrinology, Miguel Servet University Hospital, Zaragoza, Spain.
  • Samuelsson U; Diabeter, National Treatment and Research Center for Children, Adolescents and Young Adults With Type 1 Diabetes, and Department of Pediatric Endocrinology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Pruhova S; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences and Crown Princess Victoria Children's Hospital, Linköping University, Linköping, Sweden.
  • Dietrich F; Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
  • Puente Marin S; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
  • Nordlund A; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
  • Hannelius U; Trial Form Support, Lund, Sweden.
  • Casas R; Diamyd Medical AB, Stockholm, Sweden.
Diabetes Care ; 44(7): 1604-1612, 2021 07.
Article em En | MEDLINE | ID: mdl-34021020

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Glutamato Descarboxilase Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Glutamato Descarboxilase Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article